Frontiers in Medicine (Aug 2022)

Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic

  • Silvia Vázquez-Cuesta,
  • Silvia Vázquez-Cuesta,
  • Silvia Vázquez-Cuesta,
  • María Olmedo,
  • María Olmedo,
  • Elena Reigadas,
  • Elena Reigadas,
  • Elena Reigadas,
  • Elena Reigadas,
  • Luis Alcalá,
  • Luis Alcalá,
  • Luis Alcalá,
  • Mercedes Marín,
  • Mercedes Marín,
  • Mercedes Marín,
  • Mercedes Marín,
  • Patricia Muñoz,
  • Patricia Muñoz,
  • Patricia Muñoz,
  • Patricia Muñoz,
  • Emilio Bouza,
  • Emilio Bouza,
  • Emilio Bouza,
  • Emilio Bouza,
  • Emilio Bouza

DOI
https://doi.org/10.3389/fmed.2022.953724
Journal volume & issue
Vol. 9

Abstract

Read online

Information on Clostridioides difficile infection (CDI) in patients with COVID-19 is scarce and points to an overall decrease of episodes during the pandemic. This situation results paradoxical, as COVID-19 patients had long periods of hospital stay and high use of antibiotics. We conducted a retrospective study from January 1st 2019 to December 31st 2020 comparing the incidence of hospital-acquired episodes of CDI (HA-CDI) among patients with and without COVID-19 admitted to our institution. During the study period, there were 47,048 patient admissions in 2019, 35,662 admissions of patients without COVID-19 in 2020 and 6,763 of COVID-19 patients. There were 68 episodes of HA-CDI in COVID-19 patients (14.75/10,000 days), 159 in 2020-non-COVID-19 patients (5.54/10,000 days) and 238 in 2019 (6.80/10,000 days). Comparison of HA-CDI in COVID-19 and non-COVID-19 patients indicates it occurs more frequently, in terms of CDI disease severity, COVID-19 does not seem to have a negative impact.

Keywords